Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2000 Apr;37(4):245–249. doi: 10.1136/jmg.37.4.245

Localisation of the gene causing diaphyseal dysplasia Camurati-Engelmann to chromosome 19q13

K Janssens 1, R Gershoni-Baruch 1, E Van Hul 1, R Brik 1, N Guanabens 1, N Migone 1, L Verbruggen 1, S Ralston 1, M Bonduelle 1, L Van Maldergem 1, F Vanhoenacker 1, W Van Hul 1
PMCID: PMC1734563  PMID: 10745041

Abstract

Camurati-Engelmann disease, progressive diaphyseal dysplasia, or diaphyseal dysplasia Camurati-Engelmann is a rare, autosomal dominantly inherited bone disease, characterised by progressive cortical expansion and sclerosis mainly affecting the diaphyses of the long bones associated with cranial hyperostosis. The main clinical features are severe pain in the legs, muscular weakness, and a waddling gait. The underlying cause of this condition remains unknown.
In order to localise the disease causing gene, we performed a linkage study in a large Jewish-Iraqi family with 18 affected subjects in four generations. A genome wide search with highly polymorphic markers showed linkage with several markers at chromosome 19q13. A maximum lod score of 4.9 (θ=0) was obtained with markers D19S425 (58.7 cM, 19q13.1) and D19S900 (67.1 cM, 19q13.2). The disease causing gene is located in a candidate region of approximately 32 cM, flanked by markers D19S868 (55.9 cM, 19q13.1) and D19S571 (87.7 cM, 19q13.4).


Keywords: Camurati-Engelmann disease; progressive diaphyseal dysplasia; chromosome 19q13; sclerosing bone dysplasia

Full Text

The Full Text of this article is available as a PDF (145.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balemans W., Van Den Ende J., Freire Paes-Alves A., Dikkers F. G., Willems P. J., Vanhoenacker F., de Almeida-Melo N., Alves C. F., Stratakis C. A., Hill S. C. Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12-q21. Am J Hum Genet. 1999 Jun;64(6):1661–1669. doi: 10.1086/302416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bodine P. V., Harris H. A., Komm B. S. Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts. Endocrinology. 1999 Jun;140(6):2439–2451. doi: 10.1210/endo.140.6.6612. [DOI] [PubMed] [Google Scholar]
  3. Boyce B. F., Xing L., Franzoso G., Siebenlist U. Required and nonessential functions of nuclear factor-kappa B in bone cells. Bone. 1999 Jul;25(1):137–139. doi: 10.1016/s8756-3282(99)00105-2. [DOI] [PubMed] [Google Scholar]
  4. Brat H. G., Hamoir X., Matthijs P., Lambin P., Van Campenhoudt M. Camurati-Engelmann disease: a late and sporadic case with metaphyseal involvement. Eur Radiol. 1999;9(1):159–162. doi: 10.1007/s003300050648. [DOI] [PubMed] [Google Scholar]
  5. Canalis E., McCarthy T., Centrella M. Growth factors and the regulation of bone remodeling. J Clin Invest. 1988 Feb;81(2):277–281. doi: 10.1172/JCI113318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dib C., Fauré S., Fizames C., Samson D., Drouot N., Vignal A., Millasseau P., Marc S., Hazan J., Seboun E. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature. 1996 Mar 14;380(6570):152–154. doi: 10.1038/380152a0. [DOI] [PubMed] [Google Scholar]
  7. Gelb B. D., Shi G. P., Chapman H. A., Desnick R. J. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science. 1996 Aug 30;273(5279):1236–1238. doi: 10.1126/science.273.5279.1236. [DOI] [PubMed] [Google Scholar]
  8. Greenspan A. Sclerosing bone dysplasias--a target-site approach. Skeletal Radiol. 1991;20(8):561–583. doi: 10.1007/BF01106087. [DOI] [PubMed] [Google Scholar]
  9. Hanson W., Parnes L. S. Vestibular nerve compression in Camurati-Engelmann disease. Ann Otol Rhinol Laryngol. 1995 Oct;104(10 Pt 1):823–825. doi: 10.1177/000348949510401013. [DOI] [PubMed] [Google Scholar]
  10. Heaney C., Shalev H., Elbedour K., Carmi R., Staack J. B., Sheffield V. C., Beier D. R. Human autosomal recessive osteopetrosis maps to 11q13, a position predicted by comparative mapping of the murine osteosclerosis (oc) mutation. Hum Mol Genet. 1998 Sep;7(9):1407–1410. doi: 10.1093/hmg/7.9.1407. [DOI] [PubMed] [Google Scholar]
  11. Hernández M. V., Peris P., Guañabens N., Alvarez L., Monegal A., Pons F., Ponce A., Muñoz-Gómez J. Biochemical markers of bone turnover in Camurati-Engelmann disease: a report on four cases in one family. Calcif Tissue Int. 1997 Jul;61(1):48–51. doi: 10.1007/s002239900293. [DOI] [PubMed] [Google Scholar]
  12. Hoeffel J. C., Mainard L., Leyder B. Camurati-Engelmann disease. A case report. Eur Radiol. 1999;9(9):1932–1933. doi: 10.1007/s003300050952. [DOI] [PubMed] [Google Scholar]
  13. Kaftori J. K., Kleinhaus U., Naveh Y. Progressive diaphyseal dysplasia (Camurati-Engelmann): radiographic follow-up and CT findings. Radiology. 1987 Sep;164(3):777–782. doi: 10.1148/radiology.164.3.3615880. [DOI] [PubMed] [Google Scholar]
  14. Lathrop G. M., Lalouel J. M. Easy calculations of lod scores and genetic risks on small computers. Am J Hum Genet. 1984 Mar;36(2):460–465. [PMC free article] [PubMed] [Google Scholar]
  15. Naveh Y., Kaftori J. K., Alon U., Ben-David J., Berant M. Progressive diaphyseal dysplasia: genetics and clinical and radiologic manifestations. Pediatrics. 1984 Sep;74(3):399–405. [PubMed] [Google Scholar]
  16. Oursler M. J., Riggs B. L., Spelsberg T. C. Glucocorticoid-induced activation of latent transforming growth factor-beta by normal human osteoblast-like cells. Endocrinology. 1993 Nov;133(5):2187–2196. doi: 10.1210/endo.133.5.8404670. [DOI] [PubMed] [Google Scholar]
  17. Saharinen J., Taipale J., Monni O., Keski-Oja J. Identification and characterization of a new latent transforming growth factor-beta-binding protein, LTBP-4. J Biol Chem. 1998 Jul 17;273(29):18459–18469. doi: 10.1074/jbc.273.29.18459. [DOI] [PubMed] [Google Scholar]
  18. Saraiva J. M. Progressive diaphyseal dysplasia: a three-generation family with markedly variable expressivity. Am J Med Genet. 1997 Aug 22;71(3):348–352. doi: 10.1002/(sici)1096-8628(19970822)71:3<348::aid-ajmg17>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  19. Sly W. S., Hewett-Emmett D., Whyte M. P., Yu Y. S., Tashian R. E. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci U S A. 1983 May;80(9):2752–2756. doi: 10.1073/pnas.80.9.2752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sparkes R. S., Graham C. B. Camurati-Engelmann disease. Genetics and clinical manifestations with a review of the literature. J Med Genet. 1972 Mar;9(1):73–85. doi: 10.1136/jmg.9.1.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Van Hul W., Balemans W., Van Hul E., Dikkers F. G., Obee H., Stokroos R. J., Hildering P., Vanhoenacker F., Van Camp G., Willems P. J. Van Buchem disease (hyperostosis corticalis generalisata) maps to chromosome 17q12-q21. Am J Hum Genet. 1998 Feb;62(2):391–399. doi: 10.1086/301721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Van Hul W., Bollerslev J., Gram J., Van Hul E., Wuyts W., Benichou O., Vanhoenacker F., Willems P. J. Localization of a gene for autosomal dominant osteopetrosis (Albers-Schönberg disease) to chromosome 1p21. Am J Hum Genet. 1997 Aug;61(2):363–369. doi: 10.1086/514844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Whyte M. P. Heritable metabolic and dysplastic bone diseases. Endocrinol Metab Clin North Am. 1990 Mar;19(1):133–173. [PubMed] [Google Scholar]
  24. Wulczyn F. G., Naumann M., Scheidereit C. Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B. Nature. 1992 Aug 13;358(6387):597–599. doi: 10.1038/358597a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES